[작성자:] cms3billion

Although in practice guidelines from the American College of Cardiology (ACC), American Heart Association (AHA), and Heart Rhythm Society recommend genetic testing for long QT syndrome, which causes ventricular arrhythmias, only 2.5% of patients receive it. Genetic Testing for Inherited Cardiovascular Disease Inherited Cardiovascular Disease is a group of genetic disorders that affect the heart and blood…

Many rare genetic diseases show similar symptoms. However, despite similar symptoms, the genetic cause may be different. Let us take a look into progressive muscular dystrophies for example. Progressive muscular dystrophy (PMD) is a genetic disease that leads to progressive weakness in the muscles. There are over 30 different types of dystrophy per genetic mutation,…

Introduction On the website of a company providing genetic testing for rare diseases, you can easily see “increases diagnostic yield by up to 20% compared to routine WES”1, “Approximately 30% diagnostic yield”2, “Detection rates range from about 28.8% to as high as 57.5% for this patient population”3.If you search for WES diagnosis yield on PubMed,…

There are several ways to perform genetic testing. The specific method used can depend on the type of genetic condition being tested for, the specific genes or genetic mutations being targeted, and the available resources. It’s important to note that genetic testing and diagnosis can be complex and may require multiple types of testing to…

Fabry disease actually has available treatments, so early diagnosis can have significant benefits for patients. In the past, when 1,200 patients previously diagnosed with HCM were retested, 20 of them were found to have Fabry disease. It is hard to distinguish between the two diseases based on the symptoms alone since both diseases are characterized…

2024 Update: Whole Genome Sequencing Costs The field of genetic testing, particularly Whole Genome Sequencing (WGS), is experiencing transformative growth, with the global Next-Generation Sequencing (NGS) market expected to expand significantly through 2030. The most impactful driver behind this expansion is the rapid decrease in sequencing costs, which has made genetic testing more accessible and…

We recently had the exhilarating opportunity to welcome Dr. Ngu to 3billion, a day that turned out to be both enlightening and inspiring for everyone involved. Dr. Lock Hock Ngu, MBBS (Malaysia), MRCP (UK), is a Head of Genetics at Hospital Kuala Lumpur. The institution serves as Malaysia’s national referral center for inherited metabolic diseases and…

The Advent of Whole Genome Sequencing in Rare Disease Diagnostics Whole Genome Sequencing (WGS) has revolutionized the approach to diagnosing rare diseases. Unlike traditional methods that target specific genes, WGS analyzes the entire genome, offering a comprehensive view of an individual’s genetic makeup. This approach has significantly increased diagnostic yield, especially for complex or undiagnosed…

Underrepresentation in medical research Historically, there has been underrepresentation of different groups in clinical studies. While recent efforts have been made to represent all members of society in medical research, women and different ethnic groups have been underrepresented for decades. Women make up 50.8% of the U.S. population, but only accounted for 41.2% of clinical…

“Are you wrestling with the delicate balance between securing high-quality sequencing services and managing your budget constraints?” “Are you in search of a lab that provides more than just data, a partner who offers insightful interpretation and ongoing support for your research journey?” Today, we’re going to dive into that question with a guide to…